Unravelling a hidden pathology of a vertebral fracture in a teenage girl.

Unravelling a hidden pathology of a vertebral fracture in a teenage girl.

Publication date: Sep 19, 2024

Although the skeleton remains a common target of primary hyperparathyroidism, the classic bone disease “osteitis fibrosa cystica” is currently rare due to early diagnosis. This case represents severe classic bone manifestations of primary hyperparathyroidism due to delayed diagnosis and delayed medical attention. A 19-year-old young female was symptomatically managed for chronic back pain and nonspecific bone pain in the small joints of both hands over 2 months by a general practitioner. The patient had delayed seeking for treatment for 3 months. Later, she was evaluated for tuberculosis, hematological malignancies and rheumatic disorders following a fractured T12 vertebra and underwent pedicle screw fixation. However, clinical examination and investigations, including biochemistry, imaging and histology, ruled out the above conditions. Unfortunately, serum calcium level was not performed at the initial presentation. Later, primary hyperparathyroidism was diagnosed on the basis of moderate hypercalcaemia and elevated intact PTH levels (2064 pg/ml). She had sufficient vitamin D levels and normal kidney function. Her DXA scan revealed severe secondary osteoporosis with the lowest Z score of -8 at the total lumbar spine. Ultrasonography of the thyroid revealed a hypo echoic mass in the left lower neck, and localization studies with technetium-99 m sestamibi and 4D-CT revealed a left inferior parathyroid adenoma (1. 6 cD7 1. 5 cD7 1. 6 cm). CT scan also revealed brown tumors in the mandible and vertebrae and diffuse bony changes in the skull, sternum, humerus and vertebrae. Her radiographs revealed subperiosteal bone resorption on the radial aspects of the middle and distal phalanges and brown tumors in both the ulna and fibula. We excluded MEN and other hereditary syndromes in our patient with a personal and family history and with a normal pituitary hormone profile because of poor resources for genetic testing. She underwent parathyroid adenoma excision, and the postoperative period was complicated with hungry bone syndrome, requiring high doses of calcium and active vitamin D supplements. These supplements were gradually weaned off over 6 months, and she recovered with normal biochemical investigations. Histology revealed parathyroid adenoma without malignant features. In developing countries where routine calcium screening is not available, clinicians should be aware of various manifestations of primary hyperparathyroidism to allow diagnosis as soon as possible without delay to prevent further progression, as it is a treatable condition.

Open Access PDF

Concepts Keywords
Biochemistry Adenoma
Ct Adolescent
Rheumatic Delayed diagnosis
T12 Female
Vertebrae Humans
Hungry bone syndrome
Hyperparathyroidism, Primary
Osteitis Fibrosa Cystica
Osteitis fibrosa cystica
Parathyroid Neoplasms
Primary hyperparathyroidism
Spinal Fractures
Young Adult

Semantics

Type Source Name
disease MESH primary hyperparathyroidism
disease MESH bone disease
disease MESH osteitis fibrosa cystica
disease MESH back pain
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH hematological malignancies
drug DRUGBANK Parathyroid hormone
drug DRUGBANK Vitamin D
disease MESH osteoporosis
drug DRUGBANK Technetium Tc-99m
drug DRUGBANK Technetium Tc-99m sestamibi
disease MESH tumors
disease MESH syndromes
disease MESH parathyroid adenoma
drug DRUGBANK Calcium
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease IDO history
pathway REACTOME Metabolism
disease MESH bone cysts
disease MESH joint pain
disease MESH oral ulcers
disease MESH alopecia
disease MESH weight loss
disease MESH leukemia
disease MESH lymphoma
disease MESH nephrolithiasis
disease MESH nephrocalcinosis
drug DRUGBANK Phosphate ion
drug DRUGBANK Alkaline Phosphatase
drug DRUGBANK Magnesium
drug DRUGBANK Creatinine
drug DRUGBANK Hydrocortisone
drug DRUGBANK Cysteamine
disease MESH pheochromocytoma
drug DRUGBANK Esomeprazole
drug DRUGBANK Calcium Phosphate
disease MESH vitamin deficiency
disease MESH osteopenia
disease IDO country
disease MESH etiology
disease IDO symptom
disease MESH osteitis
drug DRUGBANK L-Cysteine
drug DRUGBANK Nonoxynol-9
disease MESH postmenopausal osteoporosis
disease MESH adenoma
disease MESH hyperplasia
disease MESH asymptomatic conditions
disease IDO assay
drug DRUGBANK Spinosad
disease MESH hypophosphatemia
drug DRUGBANK Trestolone
disease MESH Multiple endocrine neoplasia
disease MESH hypercalcemia
drug DRUGBANK Acetylsalicylic acid

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *